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background:  Benefits of PCI using the CorPath robotic system configured for transfemoral arterial access (TFA) have been demonstrated. 
The prevalence of transradial arterial access (TRA) in the U.S. is increasing but the feasibility and the success of robot-assisted PCI 
configured for TRA has not been investigated. 
methods:  Robotic PCI was utilized at a single center in consecutive, unmatched non-emergent PCI procedures. Technical success was 
completion of the robotic PCI without conversion to manual operation. Procedural success was PCI to <30% residual stenosis with no post-
procedure MACE. 
Results:  Robotic PCI was performed using TFA (32 procedures, 36 lesions) and TRA (36 procedures, 50 lesions). Patient and lesion 
characteristics were similar for TFA and TRA groups Table I. Multi-vessel PCI was performed in 13.9% of TRA group compared to 3% of 
TFA group (p=NS). No difference in technical (100% vs. 96%; p=NS) or procedural (100% vs. 96%; p=NS) success were seen. When 
corrected for number of lesions treated, TRA procedures continued to demonstrate longer total fluoroscopy time (14.24 vs. 10.13 min.; 
p=0.003) and procedure time (45.14 vs. 36.67 min.; p=0.009). No difference in contrast use was seen. No MACE events were reported in 
either group. 
conclusion:  Robotic-assisted PCI via TRA is feasible, safe and effective. Total fluoroscopy and procedure times were greater with TRA. 
Post-procedure MACE did not occur in either group.
table 1
Femoral(N=32 patients) Radial(N=36 patients) P-value
Age (yrs) 66.1 ± 10.0 64.1 ± 11.3 0.428
BSA (m2) 2.0 ± 0.2 2.0 ± 0.2 0.628
Men 78.1% (25/32) 72.2% (26/36) 0.575
Smoker 28.1% (9/32) 47.2% (17/36) 0.106
Diabetes mellitus 43.8% (14/32) 36.1% (13/36) 0.521
Hypertension 84.4% (27/32) 75.0% (27/36) 0.340
Hyperlipidemia 87.5% (28/32) 80.6% (29/36) 0.521
Prior MI 43.8% (14/32) 38.9% (14/36) 0.684
Prior PCI 78.1% (25/32) 55.6% (20/36) 0.050
Prior CABG 18.8% (6/32) 8.3% (3/36) 0.575
LAD 22.2% (8/36) 52.0% (26/50) 0.005
LCX 36.1% (13/36) 18.0% (9/50) 0.058
RCA 38.9% (14/36) 30.0% (15/50) 0.390
Type A lesion 44.4% (16/36) 20.0% (10/50) 0.015
B1 27.8% (10/36) 38.0% (19/50) 0.823
B2 16.7% (6/36) 38.0% (19/50) 0.032
C 11.1% (4/36) 4.0% (2/50) 0.232
